首页> 外文OA文献 >Mutation Spectrum of the ABCA4 Gene in a Greek Cohort with Stargardt Disease: Identification of Novel Mutations and Evidence of Three Prevalent Mutated Alleles
【2h】

Mutation Spectrum of the ABCA4 Gene in a Greek Cohort with Stargardt Disease: Identification of Novel Mutations and Evidence of Three Prevalent Mutated Alleles

机译:ABCA4基因在希腊群组中的突变谱与Stargardt病:鉴定新的突变和三个普遍突变等位基因的证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aim. To evaluate the frequency and pattern of disease-associated mutations of ABCA4 gene among Greek patients with presumed Stargardt disease (STGD1). Materials and Methods. A total of 59 patients were analyzed for ABCA4 mutations using the ABCR400 microarray and PCR-based sequencing of all coding exons and flanking intronic regions. MLPA analysis as well as sequencing of two regions in introns 30 and 36 reported earlier to harbor deep intronic disease-associated variants was used in 4 selected cases. Results. An overall detection rate of at least one mutant allele was achieved in 52 of the 59 patients (88.1%). Direct sequencing improved significantly the complete characterization rate, that is, identification of two mutations compared to the microarray analysis (93.1% versus 50%). In total, 40 distinct potentially disease-causing variants of the ABCA4 gene were detected, including six previously unreported potentially pathogenic variants. Among the disease-causing variants, in this cohort, the most frequent was c.5714+5G>A representing 16.1%, while p.Gly1961Glu and p.Leu541Pro represented 15.2% and 8.5%, respectively. Conclusions. By using a combination of methods, we completely molecularly diagnosed 48 of the 59 patients studied. In addition, we identified six previously unreported, potentially pathogenic ABCA4 mutations.
机译:目的。为了评估希腊的患者认为斯特格氏病(STGD1)中ABCA4基因的疾病相关的基因突变的频率和模式。材料和方法。总共有59例患者进行了分析使用ABCR400芯片和所有编码外显子进行基于PCR的测序和侧翼内含子区域ABCA4突变。 MLPA分析以及在内含子30的两个区域和36的测序之前的报道怀有深内含子疾病相关的变体在4选定的情况下被使用。结果。至少一个突变的等位基因的总检出率是在59名患者(88.1%)的52来实现的。直接测序显著提高了完整的特征率,即两个突变的鉴定比微阵列分析(93.1%对50%)。总体而言,被检测出的ABCA4基因的40不同的潜在致病变种,包括6种以前未报告的潜在致病性变异体。间致病变种,在这个队列中,最常见的是c.5714 + 5G>甲表示16.1%,而p.Gly1961Glu和p.Leu541Pro分别表示15.2%和8.5%。结论。通过使用相结合的方法,我们完全分子诊断研究的59例患者中48。此外,我们确定了六个以前未报告的,潜在的致病突变ABCA4。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号